IDEXX LABORATORIES INC /DE
In Vitro & In Vivo Diagnostic Substances·WESTBROOK, ME·FY end 12/31·CIK 874716
CEO pay mix
Jonathan J. Mazelsky · FY 2025
Stock awards$5.4M37%
Performance bonus$2.6M18%
Salary$1.1M8%
Other$5.4M37%
Performance vs. pay
TSR % vs. CEO comp actually paid · 5 fiscal years · Item 402(v) disclosure
FY
TSR
CEO comp
FY21
+32%
$28M
FY22
-18%
$-14M
FY23
+11%
$23M
FY24
-17%
$2M
FY25
+35%
$32M
CEO comp · median worker · ratio — multi-year trend
Need at least two fiscal years of proxy data to draw the trend line. The ingestion worker will populate prior-year proxies as it processes them.